Case report: sacral parasitic twins.

INTRODUCTION: Sacral parasitic twins originate from one fertilized ovum and they have one placenta and the same sex. CASE REPORT: A 23-year-old woman was referred to our clinic. Examination by touch revealed a mass that was in the sacral region but the borders could not be fully examined. The solid mass, which was conjoined to the sacrum, had a soft texture. The infant's appearance was macroscopically normal. When the mass was examined by palpation, there were structures which felt like extremities. The mass was 20 x 11 x 9 cm in size. CONCLUSION: The differential diagnosis should include sacrococcygeal teratoma. In our case the differential diagnosis was done by histopathologic findings. This case, which involved a tumoral formation at the sacral region in the antenatal period, was detected during delivery. A sacral parasite is a rarely seen phenomenon and as such the diagnostic information of this case could be useful.

A renal transplant recipient with pulmonary tuberculosis and visceral leishmaniasis: review of superimposed infections and therapy approaches.

Visceral leishmaniasis (VL) is an acute or subacute disease that is almost invariably fatal if untreated. It is a rare disease in renal transplant recipients and frequently reported together with other infectious agents. A 39-year-old renal transplant patient was admitted to hospital for elective coronary surgery. In the post-operative period, he developed spiking fever and non-productive cough and his general condition deteriorated. While he was taking medication for non-specific pneumonia, a cavitary lesion occurred in his lung, and he had the diagnosis of pulmonary tuberculosis and antituberculous treatment was started. Despite treatment, his fever continued. As the patient developed pancytopenia and splenomegaly, a bone marrow aspiration was done. Evaluation of bone marrow aspirate indicated Leishmania parasites. He was successfully treated with a more intensive liposomal amphotericin (L-AmB). Complete cure was achieved during follow-up period of 10 months without clinical relapse. In the existence of fever and long-standing pancytopenia, VL should be suspected although the patient had another proved infection and did not live or visit an endemic area. L-AmB usage can be safely preferred for treatment of selected renal transplant recipients with VL as first-line therapy.